journal article·2023-10-16Open access

Heparin-Loaded Composite Coatings on Porous Stent from Pure Magnesium for Biomedical Applications

Yu-Liang Lai, Cheng-Rui Lin, Chao-Chun Yen, Shiow-Kang Yen

Journal of Functional Biomaterials· Volume 14· Issue 10

Abstract

Challenges associated with drug-releasing stents used in percutaneous transluminal coronary angioplasty (PTCA) encompass allergic reactions, prolonged endothelial dysfunction, and delayed stent clotting. Although absorbable stents made from magnesium alloys seem promising, fast in vivo degradation and poor biocompatibility remain major challenges. In this study, zirconia (ZrO2) layers were used as the foundational coat, while calcium phosphate (CaP) served as the surface layer on unalloyed magnesium specimens. Consequently, the corrosion current density was decreased to 3.86, from 13.3 μA/cm2. Moreover, a heparin-controlled release mechanism was created by co-depositing CaP, gelatin (Gel), and heparin (Hep) on the specimens coated with CaP/ZrO2, thereby boosting magnesium’s blood compatibility and prolonging the heparin-releasing time. Techniques like X-ray diffractometry (XRD), focused ion beam (FIB) system, toluidine blue testing, UV–visible spectrometry, field emission scanning electron microscopy (FESEM), and surrogate tests for endothelial cell viability were employed to examine the heparin-infused coatings. The drug content rose to 484.19 ± 19.26 μg/cm2 in multi-layered coatings (CaP-Gel-Hep/CaP-Hep/CaP/ZrO2) from 243.56 ± 55.18 μg/cm2 in a single layer (CaP-Hep), with the controlled release spanning beyond 28 days. Also, cellular viability assessments indicated enhanced biocompatibility of the coated samples relative to those without coatings. This suggests the potential of magnesium samples after coating ZrO2 and CaP with Gel as candidates for porous biodegradable stents or even scaffolds in biomedical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Metal and Thin Film Mechanics · Corrosion Behavior and Inhibition

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physical Medicine and Rehabilitation, China Medical University Hsinchu Hospital, No. 199, Section 1, Xinglong Road, Hsinchu County 302056, Taiwan

Department of Physical Therapy and School of Medicine, China Medical University, No. 100, Section 1, Jingmao Road, Beitun District, Taichung City 406040, Taiwan

Department of Materials Science and Engineering, National Chung Hsing University, 250, Kuo-Kuang Road, Taichung City 40227, Taiwan

Funding

the Ministry of Science and Technology

References (35)

Show source-provided references
1. Biodegradable magnesium alloys as temporary orthopaedic implants: A review10.1007/s10534-019-00170-y ↗
2. Magnesium and its alloys as orthopedic biomaterials: A review10.1016/j.biomaterials.2005.10.003 ↗
3. New horizon of bioabsorbable stent10.1002/ccd.20590 ↗
4. Design of magnesium alloys with controllable degradation for biomedical implants: From bulk to surface10.1016/j.actbio.2016.09.005 ↗
5. Microstructure, mechanical properties and bio-corrosion evaluation of biodegradable AZ91-FA nanocomposites for biomedical applications10.1016/j.msea.2010.07.063 ↗
6. Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents10.1016/j.colsurfb.2010.10.038 ↗
7. Aluminum and Alzheimer’s Disease: After a Century of Controversy, Is there a Plausible Link?10.3233/JAD-2010-101494 ↗
8. Implantation of magnesium-bioresorbable scaffolds in a bifurcation under optical coherence tomography guidance
9. Corrosion protection of magnesium alloys by cerium, zirconium and niobium-based conversion coatings10.1016/j.corsci.2008.03.015 ↗
10. Characterization of electrolytic ZrO2 coating on Co–Cr–Mo implant alloys of hip prosthesis10.1016/S0142-9612(00)00133-2 ↗
11. Electrolytic MgO/ZrO2 duplex-layer coating on AZ91D magnesium alloy for corrosion resistance10.1016/j.corsci.2013.06.037 ↗
12. Hydroxyapatite particles as a controlled release carrier of protein10.1016/j.biomaterials.2003.10.081 ↗
13. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment10.1016/j.ijpharm.2016.05.046 ↗
14. Hydrothermal fabrication of porous hollow hydroxyapatite microspheres for a drug delivery system10.1016/j.msec.2016.01.055 ↗
15. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing10.1016/j.jcin.2008.12.012 ↗
16. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions10.1002/jbm.a.30524 ↗
17. Nelson, D.L., Lehninger, A.L., and Cox, M.M. (2008). Absolute Ultimate Guide for Lehninger Principles of Biochemistry, Palgrave Macmillan.
18. Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)10.1016/S0002-9149(00)00951-6 ↗
19. Development of a calcium phosphate–gelatin composite as a bone substitute and its use in drug release10.1016/S0142-9612(98)00199-9 ↗
20. Preparation and stabilization of heparin/gelatin complex coacervate microCaPsules10.1021/js9603257 ↗
21. Incorporation of heparin/BMP2 complex on GOCS-modified magnesium alloy to synergistically improve corrosion resistance, anticoagulation, and osteogenesis10.1007/s10856-021-06497-8 ↗
22. Studies on the influence of chloride ion and pH on the corrosion and electrochemical behaviour of AZ91D magnesium alloy10.1023/A:1004011916609 ↗
23. Formation and breakdown of surface films on magnesium and its alloys in aqueous solutions10.1016/j.corsci.2006.05.033 ↗
24. Electrolytic calcium phosphate/zirconia composite coating on AZ91D magnesium alloy for enhancing corrosion resistance and bioactivity10.1016/j.corsci.2015.11.029 ↗
25. A survey of bio-corrosion rates of magnesium alloys10.1016/j.corsci.2009.09.033 ↗
26. In Vitro studies of biomedical magnesium alloys in a simulated physiological environment: A review10.1016/j.actbio.2010.12.004 ↗
27. Effect of inorganic salts, amino acids and proteins on the degradation of pure magnesium in vitro10.1016/j.msec.2008.12.015 ↗
28. Colorimetric method for the assay of heparin content in immobilized heparin preparations10.1016/0003-2697(80)90679-X ↗
29. International Organization for Standardization (2009). Biological Evaluation of Medical Devices Part 5: Tests for in vitro Cytotoxicity: In Vitro Methods. Standard No. ISO 10993-5. Available online: https://www.iso.org/standard/36406.html.
30. In Vitro evaluation of cell/biomaterial interaction by MTT assay10.1016/0142-9612(93)90055-7 ↗
31. Cathodic reactions of electrolytic hydroxyapatite coating on pure titanium10.1016/S0254-0584(01)00562-4 ↗
32. Effects of electrolytic MgO coating parameters on corrosion resistance of AZ91D magnesium alloy10.1149/1.3519836 ↗
33. (2010). Standard Practice for Calculation of Corrosion Rates and Related Information from Electrochemical Measurements (Standard No. G102-89).
34. Corrosion characterization of Mg–8Li alloy in NaCl solution10.1016/j.corsci.2009.03.011 ↗
35. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation10.1016/S0168-3659(99)00078-4 ↗